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| INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, affecting 9% to 10% of the adult population in Europe and North America. 1 Chronic obstructive pulmonary disease is currently ranked the fourth most common specific cause of death globally and predicted to be the third by 2030. 2 It represents a complex chronic condition carrying a substantial impact on patients' functional capacity and influencing their quality of life, everyday activities, and autonomy in participating to social and occupational life. However, COPD definition remains controversial with poor agreement and robustness among different proposals suggested in literature so far. 3 It has also a significant impact on health care systems in costs: In 2011, the total annual cost per case in Europe was
€6147 (ERS White book)
. 4 A recent study found that in the United States, the average annual medical costs per person were $9800 among those with COPD and that costs attributable to COPD and its sequelae are estimated to increase by 2020 (Ford et al 2015) . The predominant health care cost item is hospitalization for exacerbations, accounting for $18 billion in direct costs annually in the United States, which is associated with 1-year (21%) and 5-year (55%) mortality. 5 Chronic obstructive pulmonary disease is underdiagnosed, undertreated, and not sufficiently prevented. 6 Several concerns have been raised over the reliability and applicability of different methods used to identify COPD patients in clinical care, clinical trials, and administrative databases, with difficulties in valuing the appropriate COPD treatment approach and in assessing clinical outcomes and costs. [7] [8] [9] [10] [11] One of the major difficulties about COPD is the high degree of patients exposed to inappropriate therapies. The overuse of short-acting betaagonists (SABAs) is 1 the most common examples of inappropriate treatment. Short-acting beta-agonist use ≥3 times in 2 days could represent a proxy clinical marker for identifying patients who need a re-evaluation of treatment.
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The burden COPD imposes on health care systems is mainly attributable to the type and occurrence of COPD exacerbation. 13, 14 Health administrative databases provide a powerful way of studying COPD in the population; 15 the aim of this study was to demonstrate that the use of administrative data provides a useful tool to detect patients undertreated and improve clinical governance on COPD patient population.
| METHODS

| Study population
This retrospective study used administrative data, collected during 2011 and 2012, retrieved from 3 Italian local health authorities (LHAs). The LHAs were located in 2 different Italian regions: Bassano LHA (Veneto region), Parma LHA, and Piacenza LHA (Emilia-Romagna region). All LHAs account for a total population of 522 377 inhabitants aged ≥40 years. The choice of these 2 regions is based on their innovative models for primary care. Italy's health care system is a regionally organized National Health Service; at national level, the Ministry of Health sets the fundamental principles and goals of the health system plan and allocates national funds to the regions. Regions are responsible for organizing and delivering health care. 16 In Italy, primary care is based on a network of general practitioners and family pediatricians. They are self-employed professionals, working within the National Health System through a national agreement. Emilia-Romagna region adopted the Community Health Center primary care model in 2010. 17 It is a multidisciplinary team-based health care delivery model aimed at providing continuous medical care to patients within a defined community in Community Health Centers. On the other hand, Veneto region encouraged cooperation among primary care providers through functional models such as the Community Primary Care Units to ensure continuity of care.
| COPD case identification and stratification
The algorithms applied in COPD case finding through administrative databases hitherto lack of any recognition or general agreement. 18 Thus, a new one was created from the combination of previously tested algorithms. [19] [20] [21] Three different administrative records were used to apply the algorithm: (1) hospital discharge records with diagnoses coded using the International Classification of Diseases, Ninth Revision, Clinical Modification; (2) drug dispensing records coded using Anatomic Therapeutic Chemical codes for drug classification; and (3) disease-specific exemptions from copayment for health care services. Record linkage was performed in each LHA between data files and personal identifying codes (a unique coded personal identifier) ( Figure 1 -supplemental material). Table 1 (supplemental material) displays the algorithm used to identify COPD cases. Indeed, a second algorithm was developed and used to stratify detected cases into 4 disease severity levels. The algorithm, based on drug dispensing data and hospital discharge records, is shown in Table 2 (supplemental material). Stratification according to the disease severity allows the assessment of the appropriateness of COPD management. The study referred to the GOLD 2007 COPD severity classification. 22 The method applied for stratifying cases' severity was exploratory and practice-based in essence, without any previous example in the literature. Local health authorities' administrative databases were used retrospectively, extracting data from the solar year 2011 and referring to the population aged ≥40 years in 2011.
Prevalence was estimated as the total number of existing cases divided by the number of resident subjects, aged ≥40 years in the LHA area. Gender and age distribution were computed.
| COPD case segmentation according to SABA consumption
According to Sharafkhaneh et al, COPD patients using ≥1.5 SABA doses/day are at increased risk of exacerbations.
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On this basis, data were further examined, and each COPD severity level group was segmented into 3 subgroups for detecting SABA consumption. Namely, patients using SABA less than 1 dose/week, which is the most appropriate use of SABA, patients using ≥1 SABA dose/week but less than 1.5 SABA doses/day (overuse), and patients using ≥1.5 SABA doses/day (extreme overuse).
All analyses were performed with SPSS 23.
Key points
• Health administrative databases seem beneficial for planning health care and clinical governance interventions, including COPD.
• Health administrative databases may support the identification and the stratification of COPD population according to disease staging.
• The use of SABA consumption patterns can be a reliable proxy variable to detect subgroups of patients who may require a therapy adjustment.
| RESULTS
Chronic obstructive pulmonary disease prevalence estimates in the 3 selected Italian LHAs are shown in Table 1 .
Gender distribution is reported in Table 2 .
Chronic obstructive pulmonary disease cases were stratified according to the disease severity levels by applying the disease severity algorithm shown in Table 2 (supplemental material). Table 3 displays results from the analysis of the COPD severity stratification. Distribution of patients with COPD according to disease severity and SABA use expressed as defined daily dose is reported in Table 4 . Finally, there is a correlation between SABA consumption's patterns and the increasing access to emergency services. The more SABA use grows, the more COPD patients tend to access accidents and emergency (Table 3 -supplemental material).
| DISCUSSION
| Major findings of the study
The analysis through administrative databases allowed firstly to identify patients with COPD receiving services by the 3 LHAs: The estimated average is~3% of the population aged ≥40 years with values between 2.8% and 3.2%.
Furthermore, it was also possible to stratify patients by analyzing the health consumption in hospitalization for COPD and use of respiratory drugs. Patients without hospitalization or respiratory drugs were classified as mild, those using respiratory drugs as moderate, who besides respiratory drugs were hospitalized as severe, and finally those who used oxygen as very severe. In all 3 LHA patients with moderate COPD were the majority of the population with COPD.
Finally, it was possible to distinguish patients who made an appropriate use of SABA (76% of the total), patients who had a potentially inappropriate use (20%), and those with an overuse of SABA (4%). Prevalence estimates were lower than those reported in an Italian project (VALORE) (ie, 2.9% vs 4%). 23 However, in the VALORE project, inclusion criteria for case identification were less restrictive, and no exclusion criteria were applied. Two recent studies by Soriano et al and Huaghney et al, exploiting a population-based approach, estimated the distribution of COPD COPD cases were distributed according to disease severity levels by applying the "disease severity" algorithm. according to pulmonary function tests. 24, 25 The average distribution of COPD in the 3 Italian LHAs was similar with those reported in the 2 studies. Both in the study of Soriano et al and in that of Haughney et al, patients with a moderate level of COPD were the most prevalent: 45% (Soriano et al), 52% (Huaghney et al), and 65% in our study.
A survey conducted in Germany with pulmonologists concluded that the appropriate prescription of SABA would cover no more than 5% of patients. 26 On the contrary, our study detected >45% patients treated with SABA and 4% patients using SABA ≥1.5 doses/day (Table 4) .
| Implications of the results
In light of the growing burden of chronic care conditions, such as COPD, the Institute for Healthcare Improvement, a leading organization on performance measurement at the health system level, proposed in 2008 the "Triple Aim"
strategy. 27 High-performing health systems ought to pursue the Triple Aim to (1) reduce health care costs, (2) improve population health, and (3) improve the care experience. Following these recommendations, there has been an increasing international interest in population health management approaches to strengthen accountable and integrated health delivery systems. Clinical and business intelligence are rapidly increasing in today's health care sector, driven by the population health management (PHM) framework, to assess population health, forecast health status, and classify patients (risk stratification). To meet the PHM framework, in fact, policy-makers and care providers should identify subpopulations of patients who might benefit from additional services or tailored care programs. 28 A PHM approach has been strongly suggested to address health needs along the continuum of the health care delivery system. 29 The PHM approach has been shown to provide new perspectives over the system sustainability, with a focus on the per capita cost of care understood foremost as the most appropriate care delivered within cycle or care programs, population or individually defined. In this context, the role of administrative databases is gaining increasing importance, providing promising tools to put forward and evaluate the clinical governance of most prevalent chronic care conditions with higher inappropriateness. 30 The study thus demonstrates the viability and usefulness of administrative databases to strengthen the clinical governance of patients with COPD. The innovative findings from this study rely on the advances made in using algorithms based on administrative databases to identify and stratify the COPD population according to disease staging and use of SABA. The use of SABA consumption patterns can be a reliable proxy variable to detect subgroups who may require a therapy adjustment. The subgroup with an extreme overuse of SABA, in fact, is at risk of exacerbations, and therapeutic plan should be reassessed. The reliability of SABA use as a proxy for monitoring clinical governance management is further confirmed by the relationship between the increasing use of SABA and the increasing access to accidents and emergency services (Table 3- supplemental material). This is relevant both from clinical and commissioners' perspective. The idea of "population health" 31 and the PHM framework therefore can exploit the linkages between the clinical and epidemiological approaches to tackle and manage chronic conditions, supporting the commissioners' levels, such as program planning resources, monitor appropriate utilization of health care services, and curb the cost curve. In this sense, another important implication of the study is related to the difference between the expected prevalence (9%-10%) 1 and the number of patients with COPD identified through the use of health services (3%). Data showed that~3% of the COPD population had no contact with the LHA services for COPD. The latter group included yet those who never received a diagnosis of COPD yet those who avoided contacts with the healthcare system.
| Strengths of the study
Health administrative databases seem beneficial for planning health care interventions, including the COPD field. 32 They provide robust information systems subjected to regular update and data quality controls. To this extent, as largely discussed in the literature, [33] [34] [35] administrative databases remain the prevalent data source, reliable because of the amount of data and the population coverage, especially in countries with a National Health Service System (eg, Italy or UK), easy to access, and with no relevant costs of maintenance. The study developed 2 different algorithms to evaluate the COPD population and to stratify it according to severity levels. They proved to be consistent within the study, as verified by the comparison across 3 different LHAs.
Administrative databases are a relevant data source in most OECD countries and can be used to improve population health and the quality of and the performance of health care systems. 36 Data retrieved from administrative databases can better assess the burden of disease and its temporal and spatial trends, as well as the uptake of therapeutics, with real-world implications for policy changes. 37 Furthermore, relying on robust information systems is 1 of the fundamental components of the clinical governance. 38 One of the main aims of the clinical governance is the improvement of the health care quality; to achieve this target reliable information from monitoring and evaluation system should be available. 39 One example can be based on indicators measuring compliance with standards for management of chronic diseases, such as diabetes, ischemic heart disease, and heart failure. Health care databases can provide useful and reliable results for the computation of process and outcome indicators. 40 
| Limitation of the study
The adopted algorithms are not validated, and differences because of management variability across institutional contexts, health care services' organizations or the use of inpatients' codifying systems, may influence the algorithm's performance and outcomes. Albeit more restrictive than previously tested algorithms, exclusion criteria could be not sufficiently selective to exclude patients with asthma and without COPD. Furthermore, the algorithm of disease severity ( Table 2 -supplemental material) cannot adequately detect patients with mild COPD (only 3% of patients with COPD). Consequently, the use of the algorithm could be limited because of risks of underestimation and misclassification.
| Conclusions
Study findings support the use of administrative databases for planning clinical governance strategies within a PHM framework. The administrative databases could provide a population-based perspective on some clinical issues, improving the current clinical and epidemiological knowledge based on studies carried out recruiting population samples. The information on the relationship between clinical outcomes and drug use can better inform policy-makers, primary care experts, and pulmonary medicine specialists on the pharmacological mismanagement of COPD patients, including poor adherence and inappropriate drug administration, and on the role played by some drugs or their combination on COPD prevalence. Indeed, current challenges are represented by the use of data automation with joint efforts, from different disciplinary backgrounds and roles, such as those of clinicians, health care professionals, managers, and policy-makers.
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